0
Deep & Emerging Tech·October 7, 2026·1 min read

Meta, Google DeepMind, and Isomorphic Labs invest $300M and the US invests $500M+ in Zuckerberg-backed Biohub to build open biology datasets for AI training

Share

An ~$800M push into open biology datasets means the moat in AI-first drug discovery will lean harder on proprietary assays, models, and integration into pharma workflows — not just data access. If you’re building in bio+AI, assume foundational datasets commoditize and architect around speed to insight, regulatory alignment, and partnership depth.